Today, humanity is facing a desperate crisis as we confront an invisible enemy-the novel coronavirus. Marshalling our collective wisdom, RIKEN has established a special project to provide humanity with the means to overcome this virus.
Founded around a century ago to become a cornerstone of Japan’s prosperity, RIKEN has steadily produced research outcomes across numerous fields in the natural sciences. Over the years, we have gained expertise in such areas as immunology, genetics, and structural biology through our massive life science projects. To this we add not only research in the rapidly developing fields of computational science and AI, but also a diverse array of techniques, including AI drug discovery, with which to apply our research outcomes. We are determined to mobilize these strengths and pour all our efforts into this project.
Throughout history, humanity has made excellent use of science and technology to overcome many challenges-to make the impossible, possible. Now, as we stand on the precipice of a crisis which threatens so much of what we have built, science and technology is once again being put to the test. In collaboration with research institutes, universities, and companies in Japan and abroad, RIKEN will rise to meet that test and contribute to overcoming the novel coronavirus crisis.
April 21, 2020
Hiroshi Matsumoto
President of RIKEN
Oct. 30, 2020 Trade-off with superconducting qubits overcome by quantum filter
Oct. 30, 2020 Twin study of psychosis reveals developmental signaling deficit and imbalance of excitatory and inhibitory neurons
Oct. 16, 2020 Degradation of damaged organelles in plant cells involves an unknown mechanism
Oct. 9, 2020 Computer models reliably predict light-emitting behavior of organic LED materials
Oct. 9, 2020 Fly larvae use trehalose in an unexpected way to survive severe dehydration
Oct. 8, 2020 Researchers find "missing link" between magnetars and rotation-powered pulsars
Oct. 6, 2020 Researchers use multi-ancestry comparison to refine risk factors for coronary artery disease